The sub-optimal treatment of pain is widely recognised.
This can be fully understood and quantified in the real world setting and therefore is an area of particular interest for HCD Economics.
Within our team, we have international experience in pain, particularly from the real world and patient perspective. The team have gained advocacy and research experience in neuropathic pain, gout and pain associated with auto-immune diseases.